AKT Pan (PKB) Antibody, anti-human/mouse/rat, REAfinity™
Synonyms: Protein kinase B, PKB
RECOMBINANT
Bioz Star94/100 Bioz rating
3 Citations
Clone:
REA676 | 281046
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC, MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for AKT Pan (PKB) Antibody, anti-human/mouse/rat, REAfinity™

Intracellular flow cytometry applications
APC
PE
Recommended dilution:
1:11
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-110-366, 130-110-265
Description:
Human Jurkat cells were fixed and permeabilized using the Cell Signaling Buffer Set A. Cells were then stained with Anti-AKT Pan (PKB) antibodies or with the corresponding REA Control (I) antibodies (left peak) and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris was excluded from the analysis based on scatter signals.

Application image
Recommended dilution:
1:50
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-137-400, 130-137-431
Description:
Human Jurkat cells were fixed and permeabilized using the Cell Signaling Buffer Set A. Cells were then stained with Anti-AKT Pan (PKB) antibodies or with the corresponding REA Control (I) antibodies (left peak) and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris was excluded from the analysis based on scatter signals.

Application image
Intracellular flow cytometry applications
PE
Description:
Human Jurkat cells were fixed and permeabilized using the Cell Signaling Buffer Set A. Cells were then stained with Anti-AKT Pan (PKB) antibodies or with the corresponding REA Control (I) antibodies (left peak) and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris was excluded from the analysis based on scatter signals.
MICS (MACSima Imaging Cyclic Staining) applications
APC
PE
Fixation:
FFPE
Species tested:
human
Recommended dilution:
1:11
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-110-366, 130-110-265
Fixation:
FFPE
Species tested:
human
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-137-400, 130-137-431
Testing grade:
Specifications for AKT Pan (PKB) Antibody, anti-human/mouse/rat, REAfinity™
Overview

Clone REA676 recognizes the human, mouse, and rat AKT antigen. AKT is a family of serine/threonine kinases which is also known as protein kinase B (PKB) or related to the A and C kinases (RAC-PK). AKT intricately regulates many cellular functions such as cell growth and proliferation, cell survival, apoptosis, energy metabolism, and resistance to anti-cancer therapeutics. It consists of three isoforms, AKT1, AKT2, and AKT3 (or PKBα, β, and γ). Although these three isoforms are encoded by separate genes, they share a common NH2-terminal pleckstrin homology (PH) domain, a catalytic domain in the middle, and a COOH terminus. The identity of the overall amino acid sequence of the three isoforms is very high (about 80%); however, the COOH terminus and the PH-linker region are more diverse. All three isoforms contain similar phosphorylation/activation sites: threonine 308 (AKT1), 309 (Akt2), and 305 (AKT3) and serine 473 (Akt1), 474 (AKT2), and 472 (AKT3). Phosphorylated or activated AKT regulates many of its cellular functions through the phosphorylation of a series of downstream players.

Additional information: Clone REA676 displays negligible binding to Fc receptors.

Alternative names

Protein kinase B, PKB

Detailed product information

Technical specifications

Clone
REA676
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human, mouse, rat
Antigen
AKT Pan (PKB)
Molecular mass of antigen [kDa]
56, same molecular weight for human and mouse/rat
Distribution of antigen
ubiquitous
Entrez Gene ID
RRID
AB_2651207, AB_2651208, AB_2857837, AB_2857840

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for AKT Pan (PKB) Antibody, anti-human/mouse/rat, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?